U.S. markets closed
  • S&P 500

    3,465.39
    +11.90 (+0.34%)
     
  • Dow 30

    28,335.57
    -28.09 (-0.10%)
     
  • Nasdaq

    11,548.28
    +42.28 (+0.37%)
     
  • Russell 2000

    1,640.50
    +10.25 (+0.63%)
     
  • Crude Oil

    39.78
    -0.86 (-2.12%)
     
  • Gold

    1,903.40
    -1.20 (-0.06%)
     
  • Silver

    24.70
    -0.01 (-0.04%)
     
  • EUR/USD

    1.1868
    +0.0042 (+0.36%)
     
  • 10-Yr Bond

    0.8410
    -0.0070 (-0.83%)
     
  • GBP/USD

    1.3038
    -0.0042 (-0.32%)
     
  • USD/JPY

    104.7200
    -0.1200 (-0.11%)
     
  • BTC-USD

    12,990.03
    +93.44 (+0.72%)
     
  • CMC Crypto 200

    260.05
    -1.40 (-0.54%)
     
  • FTSE 100

    5,860.28
    +74.63 (+1.29%)
     
  • Nikkei 225

    23,516.59
    +42.32 (+0.18%)
     

Largest Insider Trades of the Week

GuruFocus.com
·4 mins read

The GuruFocus All-in-One Screener can be used to find insider trades from a specific period of time or for a certain range of values. For these stock picks, I went under the Insiders tab and changed the settings for All Insider Buying to "$2,000,000+," the duration to "June 2020" and All Insider Sales to "$2,000,000+."


According to these filters, the following are this past week's most significant trades from company insiders.

Applied Molecular Transport

EPIQ Capital Group, LLC bought 2.7 million shares of Applied Molecular Transport Inc. (AMTI) for an average price of $14 on June 9.

cbe81b63a553f0c32e6622cbcfbceb68.png
cbe81b63a553f0c32e6622cbcfbceb68.png

The biotechnology company has a market cap of $778 million and an enterprise value of $760 million.

Merus

Biotechnology Value Fund LP bought 87,254 shares of Merus NV (MRUS) for an average price of $15.20 per share on June 8.

0c53ec338653379c6b21253dff4704c2.png
0c53ec338653379c6b21253dff4704c2.png

The biotechnology company has a market cap of $469 million and an enterprise value of $260 million. It has institutional ownership of 15.68% and insider ownership of 0.39%

Over the past 12 months, the stock has gained 15.33%. As of Friday, it was trading 26.73% below its 52-week high and 50.70% above its 52-week low.

Aileron Therapeutics

Director Josef H. Von Rickenbach and Muneer A. Satter bought a combined 3.9 million shares of Aileron Therapeutics Inc. (ALRN) at the average price of $1.10 per share on June 8.

f223b83752bf2914d53d7a617a1ce68c.png
f223b83752bf2914d53d7a617a1ce68c.png

The biopharmaceutical company has a market cap of $45 million and an enterprise value of $37.28 million. It has institutional ownership of 2.51% and insider ownership of 3.49%.

Over the past 12 months, the shares have increased 29%. As of Friday, the stock was trading 40.70% below its 52-week high and 372% above its 52-week low.

Cerecor

The Armistice Capital Master Fund, 10% owner and Chief Commercial Officer Archie James Harrell Jr., Interim Chief Financial Officer Christopher Ryan Sullivan and Chief Scientific Officer Garry Arthur Neil bought a combined 2 million shares of Cerecor Inc. (CERC) on June 10 and 11 for an average price of $2.36 per share.

c42a2b70699ebc6e627a58322ca82a08.png
c42a2b70699ebc6e627a58322ca82a08.png

The biopharmaceutical company has a market cap of $148 million and an enterprise value of $128 million. It has institutional ownership of 8.47% and insider ownership of 4.27%.

Over the past 12 months, the stock has lost 53.52%. As of Friday, shares were trading 60.58% below the 52-week high and 60.53% above the 52-week low.

NortonLifeLock

NortonLifeLock Inc. (NLOK) Director Peter A. Feld sold 10 million shares for an average price of $20.97 per share on June 8.

baf16eb952673e2952c7f2f1cd5e9ae9.png
baf16eb952673e2952c7f2f1cd5e9ae9.png

The seller of cybersecurity software for end-user consumers has a market cap of $11.77 billion and an enterprise value of $13.83 billion. It has insider ownership of 2.01% and institutional ownership of 64.83%.

Over the past 12 months, the stock has risen 5.99%. As of Friday, shares were trading 30.38% below the 52-week high and 32.14% above the 52-week low.

Guardant Health

The Softbank Vision Fund (AIV M1), 10% owner of Guardant Health Inc. (GH), sold 8.9 million shares for an average price of $83.16 per share on June 8.

d63f1b76ebf20b02876cfe73a31db295.png
d63f1b76ebf20b02876cfe73a31db295.png

The precision oncology company has a market cap of $7.56 billion and an enterprise value of $7.08 billion. It has insider ownership of 6.48% and institutional ownership of 41.53%.

Over the past 12 months, the stock has lost 12.25%. As of Friday, shares were trading 31.88% below the 52-week high and 36.74% above the 52-week low.

Disclosure: I do not own any stocks mentioned.

Read more here:



Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

This article first appeared on GuruFocus.